,index,gene,pagerank_score,source_disease,ensembl_gene_id,druggability_tier,hgnc_names,chr_b37,start_b37,end_b37,strand,description,no_of_gwas_regions,small_mol_druggable,bio_druggable,adme_gene
0,0,RELN,0.0576702343148327,PartialEpilepsy,ENSG00000189056,Tier 3A,RELN,7,103112231.0,103629963.0,-1.0,reelin [Source:HGNC Symbol;Acc:9957],1.0,0.6,1.0,0.6
1,1,SNCA,0.0462747411327202,LBD,ENSG00000145335,Tier 2,SNCA,4,90645250.0,90759466.0,-1.0,"synuclein, alpha (non A4 component of amyloid precursor) [Source:HGNC Symbol;Acc:11138]",13.0,1.0,1.0,0.6
1,1,SNCA,0.0462747411327202,PD,ENSG00000145335,Tier 2,SNCA,4,90645250.0,90759466.0,-1.0,"synuclein, alpha (non A4 component of amyloid precursor) [Source:HGNC Symbol;Acc:11138]",13.0,1.0,1.0,0.6
2,2,TLR4,0.0441994869074131,NeuroticDisorder,ENSG00000136869,Tier 2,TLR4,9,120466610.0,120479149.0,1.0,toll-like receptor 4 [Source:HGNC Symbol;Acc:11850],0.0,1.0,1.0,0.6
2,2,TLR4,0.0441994869074131,UnipolarDepression,ENSG00000136869,Tier 2,TLR4,9,120466610.0,120479149.0,1.0,toll-like receptor 4 [Source:HGNC Symbol;Acc:11850],0.0,1.0,1.0,0.6
3,3,APOE,0.0315830148784002,AD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,0.6,1.0,0.6
3,3,APOE,0.0315830148784002,LBD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,0.6,1.0,0.6
3,3,APOE,0.0315830148784002,PD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,0.6,1.0,0.6
4,4,GAL,0.0252298394678988,PartialEpilepsy,ENSG00000069482,Tier 3B,GAL,11,68451247.0,68458643.0,1.0,galanin/GMAP prepropeptide [Source:HGNC Symbol;Acc:4114],0.0,0.6,1.0,0.6
5,5,NOTCH3,0.0249346161691537,MigraineDisorder,ENSG00000074181,Tier 3B,NOTCH3,19,15270444.0,15311792.0,-1.0,notch 3 [Source:HGNC Symbol;Acc:7883],0.0,0.6,1.0,0.6
5,5,NOTCH3,0.0249346161691537,MigraineWithAura,ENSG00000074181,Tier 3B,NOTCH3,19,15270444.0,15311792.0,-1.0,notch 3 [Source:HGNC Symbol;Acc:7883],0.0,0.6,1.0,0.6
6,6,APP,0.0225480449096949,AD,ENSG00000142192,Tier 1,APP,21,27252861.0,27543446.0,-1.0,amyloid beta (A4) precursor protein [Source:HGNC Symbol;Acc:620],0.0,1.0,1.0,0.6
7,7,PRKD1,0.0203259731827638,BipolarDisorder,ENSG00000184304,Tier 1,PRKD1,14,30045687.0,30661104.0,-1.0,protein kinase D1 [Source:HGNC Symbol;Acc:9407],2.0,1.0,0.6,0.6
7,7,PRKD1,0.0203259731827638,Schizophrenia,ENSG00000184304,Tier 1,PRKD1,14,30045687.0,30661104.0,-1.0,protein kinase D1 [Source:HGNC Symbol;Acc:9407],2.0,1.0,0.6,0.6
8,8,DCC,0.0176024859482017,AnorexiaNervosa,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
8,8,DCC,0.0176024859482017,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
8,8,DCC,0.0176024859482017,MajorDepressiveDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
8,8,DCC,0.0176024859482017,NeuroticDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
8,8,DCC,0.0176024859482017,OCD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
8,8,DCC,0.0176024859482017,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
8,8,DCC,0.0176024859482017,TouretteSyndrome,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
8,8,DCC,0.0176024859482017,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
9,9,GRIA1,0.0138418502790259,AnorexiaNervosa,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,0.6
9,9,GRIA1,0.0138418502790259,BipolarDisorder,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,0.6
9,9,GRIA1,0.0138418502790259,OCD,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,0.6
9,9,GRIA1,0.0138418502790259,Schizophrenia,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,0.6
9,9,GRIA1,0.0138418502790259,TouretteSyndrome,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,0.6
9,9,GRIA1,0.0138418502790259,UnipolarDepression,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,0.6
10,10,FYN,0.0128662139200556,PD,ENSG00000010810,Tier 1,FYN,6,111981535.0,112194655.0,-1.0,"FYN oncogene related to SRC, FGR, YES [Source:HGNC Symbol;Acc:4037]",1.0,1.0,0.6,0.6
10,10,FYN,0.0128662139200556,Schizophrenia,ENSG00000010810,Tier 1,FYN,6,111981535.0,112194655.0,-1.0,"FYN oncogene related to SRC, FGR, YES [Source:HGNC Symbol;Acc:4037]",1.0,1.0,0.6,0.6
12,12,LGI1,0.0098396028469904,PartialEpilepsy,ENSG00000108231,Tier 3B,LGI1,10,95517566.0,95557916.0,1.0,"leucine-rich, glioma inactivated 1 [Source:HGNC Symbol;Acc:6572]",0.0,0.6,1.0,0.6
13,13,LRFN5,0.0098396028469904,AnorexiaNervosa,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
13,13,LRFN5,0.0098396028469904,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
13,13,LRFN5,0.0098396028469904,MajorDepressiveDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
13,13,LRFN5,0.0098396028469904,OCD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
13,13,LRFN5,0.0098396028469904,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
13,13,LRFN5,0.0098396028469904,TouretteSyndrome,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
13,13,LRFN5,0.0098396028469904,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
14,14,ATM,0.0097836485884011,PD,ENSG00000149311,Tier 2,ATM,11,108093211.0,108239829.0,1.0,ataxia telangiectasia mutated [Source:HGNC Symbol;Acc:795],3.0,1.0,0.6,0.6
15,15,GRIN2A,0.0085336176083661,AnorexiaNervosa,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
15,15,GRIN2A,0.0085336176083661,BipolarDisorder,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
15,15,GRIN2A,0.0085336176083661,OCD,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
15,15,GRIN2A,0.0085336176083661,PartialEpilepsy,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
15,15,GRIN2A,0.0085336176083661,Schizophrenia,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
15,15,GRIN2A,0.0085336176083661,TouretteSyndrome,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
15,15,GRIN2A,0.0085336176083661,UnipolarDepression,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
16,16,PLA2G6,0.0084483229668912,PD,ENSG00000184381,Tier 2,PLA2G6,22,38507502.0,38601697.0,-1.0,"phospholipase A2, group VI (cytosolic, calcium-independent) [Source:HGNC Symbol;Acc:9039]",4.0,1.0,0.6,0.6
18,18,SCN9A,0.0075247931269673,PartialEpilepsy,ENSG00000169432,Tier 1,SCN9A,2,167051695.0,167232503.0,-1.0,"sodium channel, voltage-gated, type IX, alpha subunit [Source:HGNC Symbol;Acc:10597]",0.0,1.0,0.6,0.6
19,19,NEGR1,0.0074839039875977,AnorexiaNervosa,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
19,19,NEGR1,0.0074839039875977,BipolarDisorder,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
19,19,NEGR1,0.0074839039875977,MajorDepressiveDisorder,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
19,19,NEGR1,0.0074839039875977,OCD,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
19,19,NEGR1,0.0074839039875977,Schizophrenia,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
19,19,NEGR1,0.0074839039875977,TouretteSyndrome,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
19,19,NEGR1,0.0074839039875977,UnipolarDepression,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
20,20,ANG,0.0074839039875977,ALS,ENSG00000214274,Tier 3B,ANG,14,21152336.0,21167130.0,1.0,"angiogenin, ribonuclease, RNase A family, 5 [Source:HGNC Symbol;Acc:483]",0.0,0.6,1.0,0.6
20,20,ANG,0.0074839039875977,FrontotemporalDementia,ENSG00000214274,Tier 3B,ANG,14,21152336.0,21167130.0,1.0,"angiogenin, ribonuclease, RNase A family, 5 [Source:HGNC Symbol;Acc:483]",0.0,0.6,1.0,0.6
21,21,ESR2,0.0074839039875977,AnorexiaNervosa,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
21,21,ESR2,0.0074839039875977,BipolarDisorder,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
21,21,ESR2,0.0074839039875977,MajorDepressiveDisorder,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
21,21,ESR2,0.0074839039875977,OCD,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
21,21,ESR2,0.0074839039875977,Schizophrenia,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
21,21,ESR2,0.0074839039875977,TouretteSyndrome,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
21,21,ESR2,0.0074839039875977,UnipolarDepression,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
22,22,CHRNB2,0.0074839039875977,PartialEpilepsy,ENSG00000160716,Tier 1,CHRNB2,1,154540257.0,154552502.0,1.0,"cholinergic receptor, nicotinic, beta 2 (neuronal) [Source:HGNC Symbol;Acc:1962]",0.0,1.0,1.0,0.6
23,23,ACE,0.0074839039875977,AD,ENSG00000159640,Tier 1,ACE,17,61554422.0,61599205.0,1.0,angiotensin I converting enzyme [Source:HGNC Symbol;Acc:2707],13.0,1.0,1.0,0.6
23,23,ACE,0.0074839039875977,IntracranialHemorrhage,ENSG00000159640,Tier 1,ACE,17,61554422.0,61599205.0,1.0,angiotensin I converting enzyme [Source:HGNC Symbol;Acc:2707],13.0,1.0,1.0,0.6
24,24,CNTN4,0.007368725529636,AnorexiaNervosa,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,0.6,1.0,0.6
24,24,CNTN4,0.007368725529636,BipolarDisorder,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,0.6,1.0,0.6
24,24,CNTN4,0.007368725529636,OCD,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,0.6,1.0,0.6
24,24,CNTN4,0.007368725529636,Schizophrenia,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,0.6,1.0,0.6
24,24,CNTN4,0.007368725529636,TouretteSyndrome,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,0.6,1.0,0.6
24,24,CNTN4,0.007368725529636,UnipolarDepression,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,0.6,1.0,0.6
25,25,SCN2A,0.0059627012655133,BipolarDisorder,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,0.6,0.6
25,25,SCN2A,0.0059627012655133,PartialEpilepsy,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,0.6,0.6
25,25,SCN2A,0.0059627012655133,PD,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,0.6,0.6
26,26,SCN1A,0.0059627012655133,MigraineDisorder,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,0.6,0.6
26,26,SCN1A,0.0059627012655133,MigraineWithAura,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,0.6,0.6
26,26,SCN1A,0.0059627012655133,PartialEpilepsy,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,0.6,0.6
27,27,CR1,0.0054851511180279,AD,ENSG00000203710,Tier 3A,CR1,1,207669492.0,207813992.0,1.0,complement component (3b/4b) receptor 1 (Knops blood group) [Source:HGNC Symbol;Acc:2334],8.0,0.6,1.0,0.6
29,29,GRM5,0.0051282051282051,BipolarDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,0.6,0.6
29,29,GRM5,0.0051282051282051,MajorDepressiveDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,0.6,0.6
29,29,GRM5,0.0051282051282051,NeuroticDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,0.6,0.6
29,29,GRM5,0.0051282051282051,UnipolarDepression,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,0.6,0.6
30,30,SORL1,0.0051282051282051,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
31,31,AKT3,0.0051282051282051,AnorexiaNervosa,ENSG00000117020,Tier 1,AKT3,1,243651535.0,244014381.0,-1.0,v-akt murine thymoma viral oncogene homolog 3 [Source:HGNC Symbol;Acc:393],1.0,1.0,0.6,0.6
31,31,AKT3,0.0051282051282051,Schizophrenia,ENSG00000117020,Tier 1,AKT3,1,243651535.0,244014381.0,-1.0,v-akt murine thymoma viral oncogene homolog 3 [Source:HGNC Symbol;Acc:393],1.0,1.0,0.6,0.6
32,32,FGFR3,0.0051282051282051,PartialEpilepsy,ENSG00000068078,Tier 1,FGFR3,4,1795034.0,1810599.0,1.0,fibroblast growth factor receptor 3 [Source:HGNC Symbol;Acc:3690],0.0,1.0,1.0,0.6
34,34,MAPT,0.0051282051282051,AD,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,0.6,0.6
34,34,MAPT,0.0051282051282051,FrontotemporalDementia,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,0.6,0.6
34,34,MAPT,0.0051282051282051,NeuroticDisorder,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,0.6,0.6
34,34,MAPT,0.0051282051282051,PD,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,0.6,0.6
34,34,MAPT,0.0051282051282051,ProgressiveSupranuclearPalsy,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,0.6,0.6
37,37,CNTNAP2,0.0051282051282051,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
37,37,CNTNAP2,0.0051282051282051,PartialEpilepsy,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
40,40,ATP2A2,0.0051282051282051,AnorexiaNervosa,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,0.6,0.6
40,40,ATP2A2,0.0051282051282051,BipolarDisorder,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,0.6,0.6
40,40,ATP2A2,0.0051282051282051,OCD,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,0.6,0.6
40,40,ATP2A2,0.0051282051282051,Schizophrenia,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,0.6,0.6
40,40,ATP2A2,0.0051282051282051,TouretteSyndrome,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,0.6,0.6
40,40,ATP2A2,0.0051282051282051,UnipolarDepression,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,0.6,0.6
42,42,CILK1,0.0051282051282051,PartialEpilepsy,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
43,43,TBK1,0.0049566264957366,ALS,ENSG00000183735,Tier 1,TBK1,12,64845660.0,64895888.0,1.0,TANK-binding kinase 1 [Source:HGNC Symbol;Acc:11584],0.0,1.0,0.6,0.6
43,43,TBK1,0.0049566264957366,FrontotemporalDementia,ENSG00000183735,Tier 1,TBK1,12,64845660.0,64895888.0,1.0,TANK-binding kinase 1 [Source:HGNC Symbol;Acc:11584],0.0,1.0,0.6,0.6
44,44,STK39,0.0049566264957366,PD,ENSG00000198648,Tier 2,STK39,2,168810530.0,169104651.0,-1.0,serine threonine kinase 39 [Source:HGNC Symbol;Acc:17717],2.0,1.0,0.6,0.6
49,49,MAPK3,0.0046870481691116,MS,ENSG00000102882,Tier 1,MAPK3,16,30125426.0,30134827.0,-1.0,mitogen-activated protein kinase 3 [Source:HGNC Symbol;Acc:6877],1.0,1.0,0.6,0.6
50,50,MAPK1,0.0046870481691116,MS,ENSG00000100030,Tier 1,MAPK1,22,22108789.0,22221970.0,-1.0,mitogen-activated protein kinase 1 [Source:HGNC Symbol;Acc:6871],1.0,1.0,0.6,0.6
71,71,CSF3,0.0039503556985088,BipolarDisorder,ENSG00000108342,Tier 3A,CSF3,17,38171614.0,38174066.0,1.0,colony stimulating factor 3 (granulocyte) [Source:HGNC Symbol;Acc:2438],8.0,0.6,1.0,0.6
73,73,BTN1A1,0.0039503556985088,BipolarDisorder,ENSG00000124557,Tier 3A,BTN1A1,6,26501449.0,26510650.0,1.0,"butyrophilin, subfamily 1, member A1 [Source:HGNC Symbol;Acc:1135]",1.0,0.6,1.0,0.6
73,73,BTN1A1,0.0039503556985088,UnipolarDepression,ENSG00000124557,Tier 3A,BTN1A1,6,26501449.0,26510650.0,1.0,"butyrophilin, subfamily 1, member A1 [Source:HGNC Symbol;Acc:1135]",1.0,0.6,1.0,0.6
75,75,PTPRD,0.0035577392219433,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
76,76,PTPRF,0.0035577392219433,AnorexiaNervosa,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,0.6,0.6
76,76,PTPRF,0.0035577392219433,BipolarDisorder,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,0.6,0.6
76,76,PTPRF,0.0035577392219433,OCD,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,0.6,0.6
76,76,PTPRF,0.0035577392219433,Schizophrenia,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,0.6,0.6
76,76,PTPRF,0.0035577392219433,TouretteSyndrome,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,0.6,0.6
76,76,PTPRF,0.0035577392219433,UnipolarDepression,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,0.6,0.6
79,79,RTN4R,0.0035577392219433,Schizophrenia,ENSG00000040608,Tier 3A,RTN4R,22,20228938.0,20270769.0,-1.0,reticulon 4 receptor [Source:HGNC Symbol;Acc:18601],0.0,1.0,1.0,0.6
81,81,UNC5C,0.0029604442143876,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
85,85,JAG1,0.0028893455419571,MigraineDisorder,ENSG00000101384,Tier 3A,JAG1,20,10618332.0,10654694.0,-1.0,jagged 1 [Source:HGNC Symbol;Acc:6188],1.0,0.6,1.0,0.6
92,92,CD80,0.0028761080980126,MS,ENSG00000121594,Tier 1,CD80,3,119243140.0,119278449.0,-1.0,CD80 molecule [Source:HGNC Symbol;Acc:1700],6.0,0.6,1.0,0.6
93,93,ADCY2,0.0028655758318035,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
93,93,ADCY2,0.0028655758318035,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
95,95,PTPRG,0.0028568952332169,AD,ENSG00000144724,Tier 3A,PTPRG,3,61547243.0,62283288.0,1.0,"protein tyrosine phosphatase, receptor type, G [Source:HGNC Symbol;Acc:9671]",0.0,1.0,1.0,0.6
96,96,VRK2,0.0028226643806774,AnorexiaNervosa,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
96,96,VRK2,0.0028226643806774,BipolarDisorder,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
96,96,VRK2,0.0028226643806774,MajorDepressiveDisorder,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
96,96,VRK2,0.0028226643806774,OCD,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
96,96,VRK2,0.0028226643806774,PartialEpilepsy,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
96,96,VRK2,0.0028226643806774,Schizophrenia,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
96,96,VRK2,0.0028226643806774,TouretteSyndrome,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
96,96,VRK2,0.0028226643806774,UnipolarDepression,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
102,102,APOB,0.0027471186967071,AD,ENSG00000084674,Tier 1,APOB,2,21224301.0,21266945.0,-1.0,apolipoprotein B [Source:HGNC Symbol;Acc:603],36.0,1.0,1.0,0.6
102,102,APOB,0.0027471186967071,BipolarDisorder,ENSG00000084674,Tier 1,APOB,2,21224301.0,21266945.0,-1.0,apolipoprotein B [Source:HGNC Symbol;Acc:603],36.0,1.0,1.0,0.6
106,106,HP,0.0027471186967071,AnorexiaNervosa,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,0.6,1.0,0.6
106,106,HP,0.0027471186967071,BipolarDisorder,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,0.6,1.0,0.6
106,106,HP,0.0027471186967071,OCD,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,0.6,1.0,0.6
106,106,HP,0.0027471186967071,Schizophrenia,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,0.6,1.0,0.6
106,106,HP,0.0027471186967071,TouretteSyndrome,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,0.6,1.0,0.6
106,106,HP,0.0027471186967071,UnipolarDepression,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,0.6,1.0,0.6
108,108,IL21,0.0027471186967071,BipolarDisorder,ENSG00000138684,Tier 3A,IL21,4,123533783.0,123542224.0,-1.0,interleukin 21 [Source:HGNC Symbol;Acc:6005],9.0,0.6,1.0,0.6
117,117,SLC10A2,0.0027366885812733,AD,ENSG00000125255,Tier 1,SLC10A2,13,103696350.0,103719196.0,-1.0,"solute carrier family 10 (sodium/bile acid cotransporter), member 2 [Source:HGNC Symbol;Acc:10906]",0.0,1.0,0.6,1.0
120,120,MMP3,0.0027366885812733,AD,ENSG00000149968,Tier 1,MMP3,11,102706532.0,102714534.0,-1.0,"matrix metallopeptidase 3 (stromelysin 1, progelatinase) [Source:HGNC Symbol;Acc:7173]",7.0,1.0,1.0,0.6
130,130,IDE,0.0027366885812733,ALS,ENSG00000119912,Tier 2,IDE,10,94211441.0,94333833.0,-1.0,insulin-degrading enzyme [Source:HGNC Symbol;Acc:5381],10.0,1.0,1.0,0.6
135,135,HDAC4,0.0027304004951389,BrainAneurysm,ENSG00000068024,Tier 1,HDAC4,2,239969864.0,240323348.0,-1.0,histone deacetylase 4 [Source:HGNC Symbol;Acc:14063],0.0,1.0,0.6,0.6
139,139,ITGA2B,0.0027304004951389,AD,ENSG00000005961,Tier 1,ITGA2B,17,42449548.0,42466873.0,-1.0,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) [Source:HGNC Symbol;Acc:6138]",1.0,1.0,1.0,0.6
139,139,ITGA2B,0.0027304004951389,PD,ENSG00000005961,Tier 1,ITGA2B,17,42449548.0,42466873.0,-1.0,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) [Source:HGNC Symbol;Acc:6138]",1.0,1.0,1.0,0.6
144,144,ITGA8,0.0027304004951389,PD,ENSG00000077943,Tier 3A,ITGA8,10,15555948.0,15762124.0,-1.0,"integrin, alpha 8 [Source:HGNC Symbol;Acc:6144]",0.0,0.6,1.0,0.6
145,145,ITGA9,0.0027304004951389,ALS,ENSG00000144668,Tier 3A,ITGA9,3,37493606.0,37865005.0,1.0,"integrin, alpha 9 [Source:HGNC Symbol;Acc:6145]",3.0,0.6,1.0,0.6
150,150,ITGB7,0.0027304004951389,Schizophrenia,ENSG00000139626,Tier 1,ITGB7,12,53585102.0,53601091.0,-1.0,"integrin, beta 7 [Source:HGNC Symbol;Acc:6162]",0.0,1.0,1.0,0.6
152,152,ITGB5,0.0027304004951389,MigraineDisorder,ENSG00000082781,Tier 1,ITGB5,3,124480795.0,124620265.0,-1.0,"integrin, beta 5 [Source:HGNC Symbol;Acc:6160]",0.0,1.0,1.0,0.6
156,156,GPR151,0.002719590357069,EssentialTremor,ENSG00000173250,Tier 3B,GPR151,5,145892666.0,145895753.0,-1.0,G protein-coupled receptor 151 [Source:HGNC Symbol;Acc:23624],0.0,1.0,0.6,0.6
161,161,TREM2,0.0026869527559493,FrontotemporalDementia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
163,163,SCARB1,0.0026869527559493,AD,ENSG00000073060,Tier 2,SCARB1,12,125261402.0,125367214.0,-1.0,"scavenger receptor class B, member 1 [Source:HGNC Symbol;Acc:1664]",6.0,1.0,0.6,0.6
169,169,LRP1,0.0026869527559493,MigraineDisorder,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,0.6,1.0,0.6
169,169,LRP1,0.0026869527559493,MigraineWithAura,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,0.6,1.0,0.6
169,169,LRP1,0.0026869527559493,Schizophrenia,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,0.6,1.0,0.6
171,171,CHRNA4,0.0026869527559493,ALS,ENSG00000101204,Tier 1,CHRNA4,20,61975420.0,62009753.0,-1.0,"cholinergic receptor, nicotinic, alpha 4 (neuronal) [Source:HGNC Symbol;Acc:1958]",0.0,1.0,0.6,0.6
171,171,CHRNA4,0.0026869527559493,FrontotemporalDementia,ENSG00000101204,Tier 1,CHRNA4,20,61975420.0,62009753.0,-1.0,"cholinergic receptor, nicotinic, alpha 4 (neuronal) [Source:HGNC Symbol;Acc:1958]",0.0,1.0,0.6,0.6
171,171,CHRNA4,0.0026869527559493,PartialEpilepsy,ENSG00000101204,Tier 1,CHRNA4,20,61975420.0,62009753.0,-1.0,"cholinergic receptor, nicotinic, alpha 4 (neuronal) [Source:HGNC Symbol;Acc:1958]",0.0,1.0,0.6,0.6
180,180,PSEN1,0.0025122460987463,AD,ENSG00000080815,Tier 1,PSEN1,14,73603126.0,73690399.0,1.0,presenilin 1 [Source:HGNC Symbol;Acc:9508],0.0,1.0,0.6,0.6
180,180,PSEN1,0.0025122460987463,FrontotemporalDementia,ENSG00000080815,Tier 1,PSEN1,14,73603126.0,73690399.0,1.0,presenilin 1 [Source:HGNC Symbol;Acc:9508],0.0,1.0,0.6,0.6
181,181,TGFB1,0.0025117217109257,MigraineDisorder,ENSG00000105329,Tier 1,TGFB1,19,41807492.0,41859816.0,-1.0,"transforming growth factor, beta 1 [Source:HGNC Symbol;Acc:11766]",1.0,1.0,1.0,0.6
182,182,SPON1,0.0025117217109257,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
183,183,IAPP,0.0025117217109257,ProgressiveSupranuclearPalsy,ENSG00000121351,Tier 1,IAPP,12,21507893.0,21532912.0,1.0,islet amyloid polypeptide [Source:HGNC Symbol;Acc:5329],0.0,0.6,1.0,1.0
194,194,TUBA4A,0.0023313226306847,ALS,ENSG00000127824,Tier 3B,TUBA4A,2,220114433.0,220142892.0,-1.0,"tubulin, alpha 4a [Source:HGNC Symbol;Acc:12407]",0.0,1.0,1.0,0.6
